Vasant Narasimhan | Novartis
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
A message about Managed Access from Vas Narasimhan CEO Novartis - YouTube
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis on LinkedIn: Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global… | 281 comments
The CEO of Novartis on Developing Drugs During a Pandemic | WIRED
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma
Novartis CEO on how yoga & lessons from his grandparents help him take big professional decisions
Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Vasant Narasimhan, vent de renouveau chez Novartis | Les Echos
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Vas Narasimhan | One Young World
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Performance slump takes toll on Novartis' CEO's 2022 payout
Quand Novartis séduit plus que Roche - Le Temps
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis - Today we announced appointment of Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as the new CEO of Novartis, effective February 1, 2018. We thank
Novartis CEO says preparedness for a new pandemic has not improved
Novartis CEO Vas Narasimhan: How We Should Think About Drug Discovery | Fortune
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook
Les jours de Vas Narasimhan à la tête de Novartis seraient comptés | Agefi.com
30 photos et images de Novartis Ceo Vas Narasimhan Interview - Getty Images
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma
